Researchers from the United Kingdom and the USA evaluated patients' willingness to pay for a prescription medication that offers complete relief of gastroesophageal reflux disease (GERD) symptoms.
Currently, over $6 billion per year is spent on prescription medication for GERD.
Patients were recruited from 5 clinical sites.
A questionnaire was used to explore patients' willingness to pay for various attributes (time to relief, amount of relief, side effects, and out-of-pocket cost) associated with GERD treatment.
Patients chose between two different combinations of attributes by indicating which scenario they preferred.
Data were gathered on health status, health-related quality of life, and sociodemographic characteristics.
A total of 205 patients completed the discrete-choice questionnaire, with a consistency rate of 99.5%.
| Patients willing to pay up to $182 for complete relief in short period of time.
| Archives of Internal Medicine |
All attributes were found to be relevant to patient decision making.
Respondents were willing to pay up to $182 to obtain complete relief in a short period of time without side effects.
Furthermore, patients with less severe GERD symptoms were willing to pay more to avoid side effects ($58 vs $38).
The authors found that older patients were less willing to pay for better relief than younger patients.
Dr Leah Kleinman, of MEDTAP International, Bethesda, Maryland, USA, said on behalf of her colleagues, "Results demonstrate that patients are willing to pay more per month for a medication that provides more complete and faster relief from GERD symptoms."
"This information can guide clinicians and formulary committees in evaluating optimal treatment for GERD," she concluded.